heel last week doj clearanc esrx deal rais
target ep vs prior reflect convict
benefit combin see sever virtu deal combin
pharmacy/med clinic horsepow attract synergi think benefit
combo appreci see strong core biz momentum
compani posit combin entiti well big beyond
final robust anticip provid financi flexibl
ep valuat risk/reward remain compel
deal lot reiter buy rate follow last week
clearanc doj surround pend esrx esrx buy
acquisit remain bullish deal integr pharmaci
benefit medic improv ci abil close gap care provid
trc evicor drive deeper collabor relationship
combin also broaden servic offer boast sizabl mail order
presenc inher treat chronic patient increas patient
touch point provid addit tool help bend cost
curv specialti remain key area client focu given signific cost
pressures/expect growth esrx scale capabl posit
combin compani well capit meaning opportun final
acquisit expect yield attract synergi produc double-
digit ep accret first full year
deepli integr valu driven service-bas model continu reson
evidenc on-going strength across busi line core global
health busi hum compani collabor care
deep penetr specialti solut data analyt capabl drive
attract absolut rel cost trend addit ci organ custom
growth remain strong continu view fund agnost model
nice align incent attract differenti addit
remain attract opportun member
plan expect increment growth govern busi
lastli global supplement group disabl life continu see strong
trend attract growth opportun esrx ytd result look good
retent rate strong adopt compani solut
continu deepen notic impact trend compani
expect adjust claim growth core busi solid
also see sizabl potenti cross-sel opportun
overlap across book busi
tr target
combin entiti throw lot continu like capit effici
compani expect combin entiti gener signific free cash flow manag expect
least free cash flow think look quit doabl allow rapid de-
lever provid financi flexibl potenti increment capit deploy opportun
compani continu project pro forma debt-to-cap within month post close
compel ep ci trade meaning discount manag care group
tie continu view misplac concern around pbm busi model
appreci benefit combin would highlight esrx current pass
pharma purchas discount price reduct rebat core pbm commerci
health plan custom addit view industri matur competit
domin market process claim highli sustain final esrx
see continu strong uptak product servic solut gener record low
drug trend client
reiter buy convict high rais price target remain bullish underli
fundament compani convict around benefit combin high
reiter buy rate rais price target continu
view risk/reward compel
page
mo pharmaci revenu
revenu
revenu
page
global provid health servic three divis global health global
supplement benefit group disabl life global health far largest
revenu offer multitud product across broad rang market person
offer local focu global supplement benefit segment provid supplement health
life accid insur select market group disabl segment
offer disabl group life accid specialti insur product primarili
buy rate ci see signific on-going opportun across busi would expect
compani highli integr value-bas approach continu reson market
look on-going share gain addit think strategic/financi benefit around pend
esrx deal underappreci view valuat risk/reward compel
valuat risk
trade ep meaning discount manag care group averag tie
larg view appreci valu pend acquisit esrx like
compani integr offer attract absolute/rel medic trend strong cash flow see
meaning opportun sever front pend express script combin
price target base ci trade ep premium current multipl still discount
peer group averag risk includ meaning exposur commerci market
view less attract growth prospect vs govern pay sizabl pend esrx
bring integr risk
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
